Your browser doesn't support javascript.
loading
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study.
Gernaat, S A M; von Stedingk, H; Hassan, M; Nilsson, H P; Rodriguez-Wallberg, K A; Hedayati, E; Rydberg, P.
Afiliación
  • Gernaat SAM; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. sofie.gernaat@gmail.com.
  • von Stedingk H; Goodpoint AB, Stockholm, Sweden.
  • Hassan M; Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden.
  • Nilsson HP; Adduct Analys, Södertälje, Sweden.
  • Rodriguez-Wallberg KA; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Hedayati E; Department of Gynecology and Reproduction, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Rydberg P; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Sci Rep ; 11(1): 2707, 2021 02 01.
Article en En | MEDLINE | ID: mdl-33526812
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ciclofosfamida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ciclofosfamida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Suecia